August 4, 2001
Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk
Article on Transgenic Enzyme Replacement Therapy Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk Van den
May 1, 2001
Exclusive Interview with Novazyme
This is an approximate transcript (i.e. from notes, not a tape) of an interview between Novazyme and the International Pompe
March 31, 2001
Clinical Trials Genzyme/Pharming
The following is a transcript of a telephone interview conducted for the IPA(International Pompe Association) by Kevin O’Donnell of the
March 30, 2001
Pharming and Genzyme to Start Study for Pompe’s Disease
Excerpt from Pharming Press Release—March 30, 2001 LEIDEN, the Netherlands, March 30, 2001 – Pharming Group N.V. announced the start
March 21, 2001
Genzyme General and Pharming Report Publication of Study Results for Pompe Disease Therapy
Excerpt From Press Release-March 20, 2001 CAMBRIDGE, MA and LEIDEN,the Netherlands—Genzyme General (Nasdaq: GENZ), a division of Genzyme Corp., and